The Viz Platform is now utilized in over 850 hospitals across the U.S. and Europe and touches almost two patients every minute. SAN FRANCISCO & PHOENIX--(BUSINESS WIRE)--Today at the Society of Vascular and Interventional Neurology (SVIN) 2021 Annual Meeting in Phoenix, Viz.ai, the world leader in AI-powered intelligent care coordination, introduced Viz ANX, the first and only AI-powered suspected cerebral aneurysm detection and care coordination platform. The 510k-pending Viz ANX algorithm will be the first AI software to automatically detect suspected aneurysms. With the launch of Viz ANX and the support of the EMBOLISE trial, Viz.ai is now leveraging its AI-powered care coordination platform to pioneer aneurysm care and clinical research. Also in 2021, the FDA cleared the Viz PE and Viz Aortic modules, making the Viz Platform multi-disciplinary.